All Posts

Proseek Bio is pleased to announce the appointment of Peter Bradley as Non-Executive Director. Peter brings extensive leadership experience across the biotechnology, medical technology, and life sciences sectors, with a strong track record of supporting innovation, commercial growth, and strategic development. His appointment strengthens Proseek Bio's Board as the company continues to advance diagnostics designed to improve earlier detection and clinical decision-making in ov

Proseek Bio is pleased to announce that our research has been accepted for presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, one of the world's leading forums for oncology research, clinical practice, and innovation. The accepted abstract, published in the Journal of Clinical Oncology, reports findings from an international collaboration between Australia and Malaysia. The study highlights the successful completion of an inter-laboratory de

We’re proud to announce that Proseek Bio has been selected to join the 2026 BioTools Innovator cohort; a globally competitive accelerator program spotlighting the most promising companies advancing life science tools and diagnostics. Chosen from a pool of nearly 550 applicants, Proseek Bio is one of just 30 companies selected, placing it among the top tier of emerging innovators in the field. This milestone reflects both the strength of our platform and the growing recognitio